STOCKHOLM, SWEDEN / ACCESSWIRE / January 31, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical
PALO ALTO, CA / ACCESSWIRE / January 31, 2024 / Bioz, Inc., a leading AI software company based in Silicon
LONDON, UK / ACCESSWIRE / January 31, 2024 / Ecora Resources PLC (LSE:ECOR)(TSX:ECOR) issues the following trading update for the
Block Admission ReturnMANCHESTER, UK / ACCESSWIRE / January 31, 2024 / THE PEBBLE GROUP PLCName of applicant:The Pebble Group PlcName
LONDON, UK / ACCESSWIRE / January 31, 2024 / Ecora Resources PLC (LSE:ECOR)(TSX:ECOR) announces that it has entered into an
LONDON, ENGLAND / ACCESSWIRE / January 31, 2024 / Argo Blockchain plc (“Argo” or “the Company”), a global leader in
Ondine Biomedical demonstrated that photodisinfection does not harm the nasal microbiomeVANCOUVER, BC / ACCESSWIRE / January 31, 2024 / Research
MagnetOs ™ Granules becomes the third product in the MagnetOs portfolio to receive FDA clearance to market for interbody useKuros